Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Bjork-Shiley cardiac valves long term results: Winnipeg experience.

Bjork-Shiley cardiac valves long term results: Winnipeg experience. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Bjork-Shiley cardiac valves long term results: Winnipeg experience. Abstract Text:

    j barwinskyJ Barwinsky,m cohenM Cohen,s bhattacharyaS Bhattacharya,s kimS Kim,j teskeyJ Teskey,

    Between April 1970 and December 1984, 1183 Bjork-Shiley cardiac valve prostheses were implanted in 915 patients (470 males, 445 females). Four types of valves were used; Delrin disc prostheses in 75 patients, pyrolytic carbon spherical disc valves in 645 patients, the 60 degrees convexo-concave disc model in 197 patients and the 70 degrees model in seven patients. Isolated mitral valve replacement was performed in 278 patients, isolated aortic valve replacement in 363 and double valve replacement in 153. Concomitant surgery was performed in 121 patients, including a modified Bentall procedure in 15. Perioperative mortality was 6.4% (nine patients undergoing isolated aortic valve replacement; 16 in mitral valve group, 18 with double valve replacement and 16 undergoing concomitant surgery). The cumulative follow-up was 4592 patient-years, to a maximum of 15 years. There were 130 late deaths, 60% due to cardiac events. Actuarial survival for the mitral valve group was as follows: four of six patients with Delrin disc valves were alive at 13.4 years; in the pyrolytic group, survival was 82% at 10 years; in the 60 degrees convexo-concave group survival was 87.5% at seven years. In the aortic valve replacement group, 83% of patients with pyrolytic valves were alive at 10 years and 85.7% of the 60 degree convexo-concave group were alive at seven years. For patients undergoing double valve replacement, 72% were still alive after seven years. Thromboembolic events averaged 1.4 per 100 patient-years. There were seven complete valve thromboses in the mitral position requiring reoperation; six of these patients were long term survivors.(ABSTRACT TRUNCATED AT 250 WORDS)

    Bjork-Shiley cardiac valves long term results: Winnipeg experience. Publishing Authors By Initials

    j barwinskyJ Barwinsky,m cohenM Cohen,s bhattacharyaS Bhattacharya,s kimS Kim,j teskeyJ Teskey,

    For similar cardiovascular diseases: vascular diseases: embolism and thrombosis: thromboembolism research abstracts see: cardiovascular diseases: vascular diseases: embolism and thrombosis: thromboembolism research

    PUBMED ID PMID:

    MEDLINE DATE:

    Bjork-Shiley cardiac valves long term results: Winnipeg experience. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Canadian journal of cardiology

    VOLUME: 4

    Page Numbers: 366-71

    Journal Abbreviation:

    ISSN: 1916-7075

    DAY: 3

    MONTH: Oct

    YEAR: 1988

    Bjork-Shiley cardiac valves long term results: Winnipeg experience. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8510280

    Bjork-Shiley cardiac valves long term results: Winnipeg experience. Keywords Mesh Terms:

    KEYWORDS: Thromboembolism

    MESH TERMS: etiology

    Chemical & Substance for Abstract: Bjork-Shiley cardiac valves long term results: Winnipeg experience. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Bjork-Shiley cardiac valves long term results: Winnipeg experience.

    AFFILIATION: Cardiovascular and Thoracic Surgery Section, St Boniface General Hospital, Winnipeg, Manitoba.

    Country: CANADA

    CANADA Research PublicationCANADA Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Can J Cardiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Bjork-Shiley cardiac valves long term results: Winnipeg experience Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News